Related Experiment Video
Updated: Aug 5, 2026
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
From 'Me too' to 'Me better' and 'Me cooler': the recent rheumatology advances in China
1Department of Rheumatology, Shanghai Renji Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
Abstract:
The past 2 years (post-COVID) have witnessed a speeding progression of rheumatology in China. This viewpoint focused on high-impact clinical investigations conducted by researchers from mainland China and highlighted China's contributions that have changed or probably will change clinical practice. It is noteworthy that China is in a process of transitioning from validation studies ('Me too' type) dominance to the enhanced therapeutic strategies and repurposing innovations ('Me better' and 'Me cooler' type), positioning itself as a key player in shaping the future of rheumatology.